Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
immunAware ApS
APS
Active
Advertising protection
CVR 39189135
Agern Alle 1, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
8 employees
https://immunaware.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
immunAware ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
AS
Anette Stryhn Buus
Chief Executive Officer
Chief Executive Officer
2018
TØ
Thomas Østerbye
Management
Management
2017
SB
Søren Buus
Management
Management
2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
PROSAL ApS — 33.33–49.99%
ASTIM Holding ApS — 25–33.32%
T.Ø. Holding ApS — 25–33.32%
83–100%
Shareholder
Type
Ownership
Votes
Since
PROSAL ApS
Company
33.33–49.99%
33.33–49.99%
2017
ASTIM Holding ApS
Company
25–33.32%
25–33.32%
2017
T.Ø. Holding ApS
Company
25–33.32%
25–33.32%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on immunAware ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
